This meeting organized by the Canceropôle Nord-Ouest and the French Plateform Cancer and Cognition, in collaboration with the University of Rouen Normandie deals with knowledge on translational research including clinical, imaging and animal models about CRCI. The objective is to bring together international specialists of the impact of cancer and treatments on brain function, addressing neuropsychological, neurobiological, and pathophysiological mechanisms, towards the search for predictive biomarkers and prevention tools.

This event will be hold on Friday 8th, July 2022 from 9:00 am to 6:15 pm in Espace Vocation Haussman Saint-Lazar – Paris 9e.

Advances in diagnostic and therapeutic strategies in oncology have significantly increased the chance of survival of cancer patients, even those with metastatic disease. However, Cancer Related Cognitive Impairment (CRCI) is frequently reported in patients treated for non-central nervous system cancer, particularly during and after chemotherapy. These cognitive deficits, are characterized by impairment of short-term and working memory, attention, executive functions, and/or processing speed. First research have primarily focused on neuropsychological tests and clinical data with chemotherapy. Since then, a growing body of literature has highlighted the potential effects of cancer itself, and a new era is emerging on the role of other cancer treatments e.g., new modalities of radiotherapy, hormone therapies, targeted therapies, and immunotherapy on neurological functions, an important issue in terms of quality of life (QoL). 

Abstract submission deadline: 3rd of June, 2022, 23:59 CET

Register and Submit an abstract by clicking here

Registration Fees: 70 €

Deadline for registrations: June 15, 2022

Maximum 100 attendees

Read more here